RxDoctor Payments Data

Alfredo Carbonell, DO

Surgery · Richmond, VANPI 1154409464

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.7%), speaking fees and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 34.7% of the total. Reporting peaked in 2019 at $41,355 and has fallen 99.4% since, to $260 in 2025. Among surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,872in general payments, 2019–2025

Across 86 payments — averaging $731.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$22K
  • W. L. Gore & Associates, Inc.$18K
  • Intuitive Surgical$18K
  • Medical Device Business Services, Inc.$4K
  • Medtronic$1K
  • Ambu Inc.$177
  • plus $472 from 6 others
$63,141in research payments, 2019–2025

Across 10 payments — averaging $6314.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$48K
  • Medtronic$16K

What the payments were for

  • Consulting fees$26,84043%
  • Speaking & faculty fees$16,29526%
  • Travel & lodging$5781%
  • Food & beverage$3,1595%
  • Education$16,00025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,872 in reported general payments places this provider in the 95th percentile of 675 surgery providers in Virginia.

See all surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$132,595
Medicare patients
189
Services billed
378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen34$53
Methocarbamol20$34

Paid to pharmacies, not to this prescriber.

Other surgery in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →